Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 27 studies | 50% ± 19% | |
macrophage | 22 studies | 35% ± 17% | |
monocyte | 19 studies | 35% ± 15% | |
non-classical monocyte | 19 studies | 36% ± 14% | |
plasmacytoid dendritic cell | 14 studies | 35% ± 14% | |
conventional dendritic cell | 13 studies | 36% ± 20% | |
dendritic cell | 10 studies | 30% ± 12% | |
myeloid cell | 10 studies | 41% ± 20% | |
basal cell | 9 studies | 28% ± 14% | |
alveolar macrophage | 8 studies | 40% ± 16% | |
epithelial cell | 8 studies | 43% ± 11% | |
ciliated cell | 7 studies | 22% ± 4% | |
neutrophil | 7 studies | 40% ± 22% | |
hematopoietic stem cell | 7 studies | 40% ± 14% | |
adipocyte | 7 studies | 26% ± 7% | |
hematopoietic precursor cell | 6 studies | 42% ± 18% | |
club cell | 6 studies | 20% ± 4% | |
respiratory goblet cell | 6 studies | 36% ± 11% | |
fibroblast | 6 studies | 27% ± 7% | |
connective tissue cell | 6 studies | 26% ± 13% | |
ionocyte | 5 studies | 28% ± 11% | |
erythroblast | 5 studies | 30% ± 7% | |
neuron | 5 studies | 38% ± 19% | |
CD8-positive, alpha-beta T cell | 5 studies | 17% ± 2% | |
secretory cell | 4 studies | 30% ± 7% | |
squamous epithelial cell | 4 studies | 44% ± 16% | |
platelet | 4 studies | 31% ± 13% | |
intermediate monocyte | 4 studies | 55% ± 10% | |
natural killer cell | 4 studies | 20% ± 4% | |
CD4-positive, alpha-beta T cell | 4 studies | 22% ± 4% | |
plasmablast | 3 studies | 34% ± 14% | |
neural crest cell | 3 studies | 22% ± 3% | |
progenitor cell | 3 studies | 32% ± 11% | |
endothelial cell | 3 studies | 22% ± 4% | |
placental villous trophoblast | 3 studies | 29% ± 2% | |
common myeloid progenitor | 3 studies | 43% ± 23% | |
mononuclear phagocyte | 3 studies | 30% ± 5% | |
tissue-resident macrophage | 3 studies | 18% ± 1% | |
glutamatergic neuron | 3 studies | 28% ± 12% | |
abnormal cell | 3 studies | 23% ± 6% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 40% ± 33% | |
transit amplifying cell | 3 studies | 29% ± 7% | |
memory B cell | 3 studies | 20% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 7908.93 | 459 / 459 | 99% | 160.91 | 1111 / 1118 |
thymus | 100% | 5792.00 | 651 / 653 | 100% | 139.26 | 602 / 605 |
bladder | 100% | 4125.90 | 21 / 21 | 99% | 255.06 | 498 / 504 |
lung | 100% | 8425.08 | 576 / 578 | 99% | 369.76 | 1142 / 1155 |
skin | 99% | 5306.97 | 1798 / 1809 | 97% | 126.51 | 458 / 472 |
ovary | 96% | 3008.15 | 173 / 180 | 98% | 109.75 | 423 / 430 |
prostate | 95% | 2830.18 | 233 / 245 | 99% | 105.76 | 495 / 502 |
brain | 93% | 3119.39 | 2468 / 2642 | 100% | 150.93 | 705 / 705 |
kidney | 100% | 4223.84 | 89 / 89 | 92% | 76.51 | 829 / 901 |
stomach | 93% | 4144.73 | 333 / 359 | 98% | 134.29 | 280 / 286 |
liver | 92% | 3753.39 | 208 / 226 | 94% | 104.79 | 381 / 406 |
adrenal gland | 97% | 4370.83 | 251 / 258 | 87% | 76.68 | 200 / 230 |
esophagus | 81% | 17267.17 | 1176 / 1445 | 100% | 238.28 | 183 / 183 |
intestine | 79% | 2980.36 | 767 / 966 | 99% | 155.46 | 521 / 527 |
uterus | 69% | 1893.91 | 118 / 170 | 99% | 290.54 | 456 / 459 |
pancreas | 49% | 1072.98 | 162 / 328 | 98% | 122.35 | 175 / 178 |
adipose | 100% | 10110.20 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 217.45 | 29 / 29 |
peripheral blood | 100% | 45590.99 | 929 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 323.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 128.27 | 1 / 1 |
spleen | 99% | 9710.25 | 238 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 64.66 | 67 / 80 |
heart | 66% | 1636.33 | 564 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 56% | 1710.12 | 754 / 1335 | 0% | 0 | 0 / 0 |
muscle | 56% | 1350.14 | 451 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009051 | Biological process | pentose-phosphate shunt, oxidative branch |
GO_0006098 | Biological process | pentose-phosphate shunt |
GO_0046177 | Biological process | D-gluconate catabolic process |
GO_0019322 | Biological process | pentose biosynthetic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0004616 | Molecular function | phosphogluconate dehydrogenase (decarboxylating) activity |
GO_0050661 | Molecular function | NADP binding |
Gene name | PGD |
Protein name | Phosphogluconate dehydrogenase 6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44) phosphogluconate dehydrogenase (NADP(+)-dependent, decarboxylating) (EC 1.1.1.44) |
Synonyms | PGDH |
Description | FUNCTION: Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH. . FUNCTION: Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH. . FUNCTION: Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH. . FUNCTION: Catalyzes the oxidative decarboxylation of 6-phosphogluconate to ribulose 5-phosphate and CO(2), with concomitant reduction of NADP to NADPH. . |
Accessions | ENST00000465632.5 K7EM49 K7EJT3 ENST00000491493.5 K7ELN9 ENST00000460189.1 ENST00000477958.5 P52209 ENST00000270776.13 [P52209-1] ENST00000483936.5 K7EMN2 K7EPF6 |